This site is intended for healthcare professionals
  • Home
  • /
  • News
  • /
  • Phase III clinical study of JTA 004 commences to r...
News

Phase III clinical study of JTA 004 commences to reduce osteoarthritis pain in the knee.- Bone Therapeutics

Read time: 1 mins
Last updated:19th May 2020
Published:19th May 2020
Condition: Pain:Osteoarthritis/ Knee
Type: drug
Register now for full access to medthority.com